Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
for the ODYSSEY OUTCOMES Investigators
Research output: Contribution to journal › Article › peer-review
90Scopus
citations
Fingerprint
Dive into the research topics of 'Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab'. Together they form a unique fingerprint.
Keyphrases
Pharmacology, Toxicology and Pharmaceutical Science